Pages that link to "Q40431661"
Jump to navigation
Jump to search
The following pages link to Sophie Piperno-Neumann (Q40431661):
Displaying 32 items.
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study (Q24812405) (← links)
- Upcoming translational challenges for uveal melanoma (Q26778535) (← links)
- Targeting Bcl-2/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenografts (Q28538631) (← links)
- Phase-II trials in osteosarcoma recurrences: A systematic review of past experience (Q30235839) (← links)
- Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes). (Q31018689) (← links)
- Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis (Q33370331) (← links)
- Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study (Q33381250) (← links)
- Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial (Q33421348) (← links)
- Results of 32 allograft-prosthesis composite reconstructions of the proximal femur (Q33631297) (← links)
- Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma (Q33659480) (← links)
- Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study (Q33805555) (← links)
- The off-label use of targeted therapies in sarcomas: the OUTC'S program (Q34897996) (← links)
- Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO). (Q35776264) (← links)
- Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient-derived xenografts (Q36264686) (← links)
- Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage (Q36549378) (← links)
- Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma (Q36673510) (← links)
- SF3B1 mutations are associated with alternative splicing in uveal melanoma (Q37660348) (← links)
- Therapeutic options in metastatic uveal melanoma (Q37951351) (← links)
- Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas (Q38186853) (← links)
- Patient-derived xenografts recapitulate molecular features of human uveal melanomas (Q38317188) (← links)
- Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial (Q38374773) (← links)
- Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma (Q38395321) (← links)
- Protein Tyrosine Phosphatase 4A3 (PTP4A3) Promotes Human Uveal Melanoma Aggressiveness Through Membrane Accumulation of Matrix Metalloproteinase 14 (MMP14). (Q38776846) (← links)
- Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial (Q38870980) (← links)
- Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target (Q38978135) (← links)
- Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial (Q38983361) (← links)
- Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics (Q39483197) (← links)
- Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases (Q40009512) (← links)
- (Q93071538) (redirect page) (← links)
- Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study (Q93071544) (← links)
- Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Methods Study (Q113223260) (← links)
- Wikidata:WikiCite/Wikidata lists/Items about RNA-Seq (← links | edit)